Rabindra Patnaik

2.2k total citations · 1 hit paper
11 papers, 1.8k citations indexed

About

Rabindra Patnaik is a scholar working on Statistics and Probability, Management Science and Operations Research and Computational Theory and Mathematics. According to data from OpenAlex, Rabindra Patnaik has authored 11 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Statistics and Probability, 5 papers in Management Science and Operations Research and 4 papers in Computational Theory and Mathematics. Recurrent topics in Rabindra Patnaik's work include Statistical Methods in Clinical Trials (7 papers), Optimal Experimental Design Methods (5 papers) and Computational Drug Discovery Methods (4 papers). Rabindra Patnaik is often cited by papers focused on Statistical Methods in Clinical Trials (7 papers), Optimal Experimental Design Methods (5 papers) and Computational Drug Discovery Methods (4 papers). Rabindra Patnaik collaborates with scholars based in United States, Canada and Germany. Rabindra Patnaik's co-authors include Vinod P. Shah, Mark L. Powell, Avraham Yacobi, Gordon McKay, Alfred Tonelli, Kamal K. Midha, John W. A. Findlay, C.T. Viswanathan, James D. Hulse and Howard Hill and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Statistics in Medicine and Pharmaceutical Research.

In The Last Decade

Rabindra Patnaik

11 papers receiving 1.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bioanalytical Method Validation—A Revisit with a Decade of Progress

2000 1.4k citations Vinod P. Shah, Kamal K. Midha et al. Pharmaceutical Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rabindra Patnaik United States	8	397	368	309	251	250	11	1.8k
Dale P. Conner United States	24	374 0.9×	221 0.6×	256 0.8×	395 1.6×	289 1.2×	56	2.7k
Gordon McKay Canada	17	436 1.1×	486 1.3×	268 0.9×	61 0.2×	266 1.1×	23	2.1k
Shrikant V. Dighe United States	11	402 1.0×	336 0.9×	167 0.5×	86 0.3×	372 1.5×	20	1.7k
Henning Blume Germany	25	338 0.9×	215 0.6×	102 0.3×	177 0.7×	265 1.1×	89	2.1k
Howard Hill United Kingdom	13	688 1.7×	380 1.0×	581 1.9×	85 0.3×	323 1.3×	46	2.2k
Kenneth A. Pittman United States	17	478 1.2×	520 1.4×	165 0.5×	72 0.3×	352 1.4×	32	2.2k
James D. Hulse United States	18	521 1.3×	410 1.1×	269 0.9×	50 0.2×	311 1.2×	31	2.2k
Anthony J. DeStefano United States	11	578 1.5×	301 0.8×	556 1.8×	105 0.4×	322 1.3×	24	1.9k
Surendra K. Bansal United States	19	750 1.9×	302 0.8×	478 1.5×	77 0.3×	223 0.9×	45	2.1k
Alfred Tonelli United States	12	477 1.2×	434 1.2×	286 0.9×	40 0.2×	261 1.0×	25	2.0k

Countries citing papers authored by Rabindra Patnaik

Since Specialization

Citations

This map shows the geographic impact of Rabindra Patnaik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rabindra Patnaik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rabindra Patnaik more than expected).

Fields of papers citing papers by Rabindra Patnaik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rabindra Patnaik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rabindra Patnaik. The network helps show where Rabindra Patnaik may publish in the future.

Co-authorship network of co-authors of Rabindra Patnaik

This figure shows the co-authorship network connecting the top 25 collaborators of Rabindra Patnaik. A scholar is included among the top collaborators of Rabindra Patnaik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rabindra Patnaik. Rabindra Patnaik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Patnaik, Rabindra. (2004). Bioequivalence Assessment: Approaches, Designs, and Statistical Considerations. 1 indexed citations

2.

Shah, Vinod, Rabindra Patnaik, Wallace P. Adams, et al.. (2001). Bioavailability and Bioequivalence: An FDA Regulatory Overview. Pharmaceutical Research. 18(12). 1645–1650. 137 indexed citations

3.

Shah, Vinod P., Kamal K. Midha, John W. A. Findlay, et al.. (2000). Bioanalytical Method Validation—A Revisit with a Decade of Progress. Pharmaceutical Research. 17(12). 1551–1557. 1353 indexed citations breakdown →

4.

Chen, Mei‐Ling, Rabindra Patnaik, Walter W. Hauck, et al.. (2000). An individual bioequivalence criterion: regulatory considerations. Statistics in Medicine. 19(20). 2821–2842. 42 indexed citations

5.

Hauck, Walter W., et al.. (2000). Subject-by-Formulation Interaction in Bioequivalence: Conceptual and Statistical Issues. Pharmaceutical Research. 17(4). 375–380. 30 indexed citations

6.

Straughn, Arthur B., Eric J. Jarvi, Kennerly S. Patrick, et al.. (2000). Bioequivalence of Methylphenidate Immediate-Release Tablets Using a Replicated Study Design to Characterize Intrasubject Variability. Pharmaceutical Research. 17(4). 381–384. 27 indexed citations

7.

Chen, Mei‐Ling, Rabindra Patnaik, Walter W. Hauck, et al.. (2000). An individual bioequivalence criterion: regulatory considerations. Statistics in Medicine. 19(20). 2821–2842. 2 indexed citations

8.

Patnaik, Rabindra, Lawrence J. Lesko, Mei Ling Chen, & Roger Williams. (1997). Individual Bioequivalence. Clinical Pharmacokinetics. 33(1). 1–6. 56 indexed citations

9.

Bois, Frédéric Y., Thomas N. Tozer, Walter W. Hauck, et al.. (1994). Bioequivalence: Performance of Several Measures of Extent of Absorption. Pharmaceutical Research. 11(5). 715–722. 54 indexed citations

10.

Bois, Frédéric Y., Thomas N. Tozer, Walter W. Hauck, et al.. (1994). Bioequivalence: Performance of Several Measures of Rate of Absorption. Pharmaceutical Research. 11(7). 966–974. 83 indexed citations

11.

Mazumder, Amitabha, Rabindra Patnaik, Belur S. Bhagavan, & Padmanabhan P. Nair. (1979). Isolation and Characterization of Attached and Nonattached Populations of Rat Colon Epithelial Cells in Culture. JNCI Journal of the National Cancer Institute. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact